Study: NCT06533475

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin Granules in capsule under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Granules in capsule under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin Granules in capsule under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Granules in capsule under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin Granules in capsule under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Granules in capsule under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin Granules in capsule under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Granules in capsule under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin Granules in capsule under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Granules in capsule under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin Granules in capsule under fasting condition
Description: Drug: Minzasolmin Pharmaceutical form: Granules in capsule under fasting condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fed condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fed condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fed condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fed condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fed condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fed condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fed condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fed condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fed condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fed condition

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minzasolmin tablet formulation under fed condition
Description: Drug: Minzasolmin Pharmaceutical form: Tablet formulation under fed condition